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Calexcitin was ﬁrst identiﬁed in the marine snail Hermissenda crassicornis as
a neuronal-speciﬁc protein that becomes upregulated and phosphorylated in
associative learning. Calexcitin possesses four EF-hand motifs, but only the ﬁrst
three (EF-1 to EF-3) are involved in binding metal ions. Past work has indicated
that under physiological conditions EF-1 and EF-2 bind Mg2+ and Ca2+, while
EF-3 is likely to bind only Ca2+. The fourth EF-hand is nonfunctional owing
to a lack of key metal-binding residues. The aim of this study was to use a
crystallographic approach to determine which of the three metal-binding sites of
calexcitin is most readily replaced by exogenous metal ions, potentially shedding
light on which of the EF-hands play a ‘sensory’ role in neuronal calcium
signalling. By co-crystallizing recombinant calexcitin with equimolar Gd3+ in the
presence of trace Ca2+, EF-1 was shown to become fully occupied by Gd3+ ions,
while the other two sites remain fully occupied by Ca2+. The structure of the
Gd3+–calexcitin complex has been reﬁned to an R factor of 21.5% and an Rfree of
30.4% at 2.2 A˚ resolution. These ﬁndings suggest that EF-1 of calexcitin is the
Ca2+-binding site with the lowest selectivity for Ca2+, and the implications of this
ﬁnding for calcium sensing in neuronal signalling pathways are discussed.
1. Introduction
A central endeavour in the ﬁeld of neuroscience is to under-
stand the complex information processing performed by
biological neural networks that underlies animal behaviour.
Paramount to this pursuit is the investigation of the processes
of learning and memory, as well as the biophysical and
molecular mechanisms that make such processes possible
(Giese et al., 2001). Owing to the complexity of vertebrate
nervous systems, initial insights into the molecular basis of
memory have been obtained from more amenable experi-
mental invertebrate models with far simpler neural networks,
containing many orders of magnitude fewer neurons (Alkon,
1983).
In much of the seminal work of Alkon and coworkers,
memory-speciﬁc biochemical changes were investigated using
a classical Pavlovian conditioning paradigm in Hermissenda
crassicornis. In this nudibranch mollusc, pairing of light and
rotation creates an association between the usually attractive
stimulus of light and foot retraction, which is usually an
aversive response to movement. Studies of changes in
neuronal physiology and molecular composition of photo-
receptor cells that correlated speciﬁcally with the learned
behaviour were undertaken (Nelson & Alkon, 1988, 1990,
1997; Alkon, 1979; Alkon et al., 1990; Kawai et al., 2002). This
work demonstrated the upregulation and phosphorylation of a
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neuron-speciﬁc 20 kDa protein (Neary et al., 1981), which
was subsequently termed calexcitin. This protein was found to
have GTPase activity and could reproduce the electro-
physiological effects of conditioning when injected into
photoreceptor cells (Nelson et al., 1990). Furthermore, it was
found that phosphorylation of calexcitin, which is mediated by
protein kinase C, caused its translocation from cytosolic to
membrane fractions (Nelson & Alkon, 1995).
Cloning and sequencing of a squid homologue of calexcitin
from the optic lobe of Loligo pealei (Nelson et al., 1996)
showed a number of interesting features such as the presence
of three functional EF-hand binding motifs which form Ca2+-
and Mg2+-binding sites (Gombos et al., 2001). Electro-
physiological studies using recombinant squid calexcitin and
human ﬁbroblast inside-out patches also showed that the
protein is capable of directly regulating K+-channel mean
open time and probability in the presence of Ca2+ (Nelson et
al., 1996). Furthermore, investigation using sensory and
chemical blocks during learning in Hermissenda established
calexcitin as being necessary to establish and consolidate long-
term memory (Kuzirian et al., 2001, 2003; Borley et al., 2002;
Child et al., 2003; Epstein et al., 2003). Additional experi-
mental evidence has also implicated calexcitin in several
mechanisms that could enable it to functionally alter neuronal
physiology. Presynaptically, calexcitin is thought to be a key
constituent of terminal nerve endings (Eyman et al., 2003) and
to regulate retrograde axonal transport (Moshiach et al.,
1993). Furthermore, postsynaptically it may alter dendritic
morphology upon phosphorylation (Lederhendler et al., 1990)
and can transform synaptic outputs from inhibitory to exci-
tatory potentials (Sun et al., 1999). Noteworthy evidence has
furthermore suggested that its postsynaptic effects could result
from the modulation of intracellular Ca2+ levels by direct
interaction with the ryanodine receptor, facilitating Ca2+
release from intracellular stores (Nelson et al., 1999).
Although calexcitin shows the highest homology to the
sarcoplasmic calcium-binding protein (SCP) family, past work
identiﬁed protein features consistent with a calcium-sensor
function.
X-ray and NMR structural studies ultimately demonstrated
that calexcitin is primarily an -helical protein organized
into two separate domains, each with two EF-hand motifs,
although the last one is nonfunctional (Erskine et al., 2006;
Gombos et al., 2006). The two domains appear to adopt a
closed conformation with a pronounced hydrophobic core
which is similar to that found in calmodulin, suggesting that
domain movements allow calexcitin to interact with binding-
partner proteins (Erskine et al., 2006; Gombos et al., 2003).
The most recent data from NMR and molecular-simulation
studies suggested that the domains have sufﬁcient ﬂexibility in
solution to allow opening of the inter-domain hydrophobic
cleft (Erskine et al., 2015).
Titration studies have indicated that calexcitin has different
afﬁnities for Ca2+ ions depending on the Mg2+ concentration
(Gombos et al., 2003). In the absence of Mg2+ the apparent Kd
for Ca2+ is 0.77 mM (range 0.37–3.3 mM), which changes to
2.58 mM (range 1.5–4.8 mM) in the presence of 2 mMMg2+. In
quiescent neurons the Ca2+ concentation is in the 10–100 nM
range and the presence of Mg2+ means that even the high-
afﬁnity site(s) will probably not be occupied by Ca2+. During
cellular activation, the intracellular level of Ca2+ increases to
the micromolar range and can be further elevated in particular
cellular compartments. Thus, it is likely that all three sites will
be occupied by Ca2+ during neuronal activation.
There is uncertainty as to which of the metal-binding sites of
calexcitin has a sensory role in the neuron and also as to how
the sites give rise to the different measurable Ca2+ afﬁnities
(Gombos et al., 2003). Our aim is to deﬁne how the metal-
binding sites of this protein allow it to act as a calcium sensor
in a similar manner to calmodulin, which is known to adopt a
signiﬁcantly different structure at high Ca2+ concentration.
Understanding the structural basis of calcium sensing by
EF-hand proteins is an important objective in deﬁning how
intracellular signalling pathways operate. To address some of
these questions, we have crystallized recombinant calexcitin in
calcium-free buffer in the presence of an equimolar concen-
tration of the heavy atom gadolinium and only trace Ca2+.
Lanthanide ions such as Gd3+ are well known for binding at
Ca2+-binding sites in proteins owing to their unique chemical
property known as lanthanide contraction. This arises from
poorer shielding of valence electrons by the 4f electrons in the
lanthanide elements, such that the increase in nuclear charge
across this series of the periodic table causes an enhanced
reduction in ionic radius. We have co-crystallized calexcitin
with equimolar Gd3+ in the presence of only trace Ca2+ and
determined the structure at 2.2 A˚ resolution, demonstrating
that Gd3+ binds at EF-1, the ﬁrst EF-hand in the N-terminal
domain of the protein, and suggesting that this is the site with
the lowest selectivity for Ca2+.
2. Methods
2.1. Expression and crystallization of the calexcitin–Gd3+
complex
His-tagged L. pealei calexcitin was expressed in Escherichia
coli and puriﬁed as described previously (Beaven et al., 2005;
Erskine et al., 2006), except that protease inhibitors were not
used during puriﬁcation. A 1 ml aliquot of puriﬁed calexcitin
at a concentration of 4 mg ml1 was dialyzed overnight against
a 1 l volume of 50 mM Tris pH 7.5, 100 mM NaCl, 1 mM
-mercaptoethanol that was made without adding any CaCl2,
which is normally present in the crystallization buffer at a
concentration of 1 mM. After dialysis, the protein at a
concentration of 2.6 mg ml1 (60 mM) was mixed with GdCl3
to give an equimolar ratio and was subjected to the Morpheus
HT-96 (Gorrec, 2009) and PACT premier HT-96 (Newman
et al., 2005) crystal screens using a Mosquito robot (TTP
Labtech) to mix 400 nl well solution and 400 nl protein solu-
tion. Molecular Dimensions Structure Screens 1 + 2 (Jancarik
& Kim, 1991; Wooh et al., 2003) were also used in 24-well plate
format by mixing 3 ml well solution and 3 ml protein solution.
Crystals suitable for diffraction experiments were obtained
from two Structure Screen 1 conditions (0.2M sodium acetate
trihydrate, 0.1M sodium cacodylate pH 6.5, 30% PEG 8000
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and 0.2M sodium acetate trihydrate, 0.1M Tris pH 8.5, 30%
PEG 4000). Crystals from the latter condition were cryopro-
tected by the addition of glycerol to a ﬁnal concentration of
30%, mounted in 0.2 mm LithoLoops (Molecular Dimen-
sions) on 18 mm CrystalCap pins (Hampton Research) and
ﬁnally ﬂashed-cooled in a nitrogen-gas cryostream (Oxford
Cryosystems) at a temperature of 100 K for storage in liquid
nitrogen.
2.2. X-ray data collection and processing
Synchrotron X-ray data for the calexcitin co-crystals were
collected on the I04 beamline at the Diamond Light Source
facility (DLS), Didcot, England using a Pilatus 6M-F detector.
A total of 190 images, each with an oscillation angle of 1 and
an exposure time of 3 s, were recorded with a beam size of 20
 20 mm and a transmission of 33%. The data were processed
with MOSFLM (Leslie & Powell, 2007) and scaled using
SCALA (Evans, 2006) in the CCP4 program suite (Winn et al.,
2011), keeping the Friedel mates separate to allow analysis of
anomalous differences. The scaling statistics for alternative
point groups and inspection of systematic absences indicated
that the space group was either P41 or P43, with unit-cell
parameters a = b = 77.0, c = 29.3 A˚. Use of the MATTPROB
server (Kantardjieff & Rupp, 2003) indicated that the crystals
contained one molecule per asymmetric unit, with a solvent
content of 38%. The structure was determined by molecular
replacement with a monomer of the native protein (PDB entry
2ccm; Erskine et al., 2006) as the search model. Phaser (McCoy
et al., 2007) found a solution in space group P43, and the
resulting maps were interpreted using Coot (Emsley &
Cowtan, 2004; Emsley et al., 2010) prior to reﬁnement of the
model using REFMAC5 (Murshudov et al., 1997, 2011) and
PHENIX (Adams et al., 2010). The latter program was used
for the reﬁnement of group TLS parameters, and the metal
anomalous scattering factors were reﬁned using the I(+) and
I() data. The resulting structure and data have been
deposited in the Protein Data Bank with identiﬁer 5f6t.
3. Results
Data-processing and reﬁnement statistics for the gadolinium
complex are shown in Table 1, where it can be seen that the
research communications
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Table 1
X-ray data-processing and reﬁnement statistics for the calexcitin–Gd3+
complex.
Values in parentheses are for the outer resolution shell.
Beamline I04, DLS
Wavelength (A˚) 0.9173
Space group P43
Unit-cell parameters
a = b (A˚) 77.0
c (A˚) 29.3
Solvent content (%) 37.7
No. of monomers per asymmetric unit 1
Matthews coefﬁcient (A˚3 Da1) 2.0
Mosaic spread () 0.8
Resolution (A˚) 29.3–2.2 (2.3–2.2)
Rmerge† (%) 13.7 (139.0)
Rmeas‡ (%) 15.2 (156.4)
CC1/2§ (%) 99.6 (34.8)
Completeness (%) 100.0 (100.0)
Average I/(I) 7.5 (1.5)
Multiplicity 6.1 (6.0)
No. of observed reﬂections 54653
No. of unique reﬂections 9020
Wilson plot B factor (A˚2) 66.2
R factor (%) 21.5 (39.6)
Free R factor (%) 30.4 (46.8)
R.m.s.d., bond lengths (A˚) 0.009
R.m.s.d., bond angles () 1.058
No. of I(+) and I() in working set 16100
No. of reﬂections in test set 870
Mean protein B factor (A˚2) 61.5
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ. ‡ Rmeas =P
hklfNðhklÞ=½NðhklÞ  1g1=2
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ. § Half-set corre-
lation coefﬁcients of Karplus & Diederichs (2012).
Figure 1
The difference electron density for the three metal-binding sites of calexcitin co-crystallized with equimolar Gd3+ in the presence of trace Ca2+. The Ca2+-
binding sites formed by EF-hands 1–3 are shown in (a), (b) and (c), respectively, with the ﬁnal reﬁned position of each metal ion shown by a grey sphere.
The OMITelectron density is contoured at 5 r.m.s. (blue) and at 15 r.m.s. (dark blue). A peak in EF-1 exceeding 18 r.m.s. indicated the presence of Gd3+,
whereas EF-2 and EF-3 had peaks of around 7 r.m.s., indicating that these retain Ca2+. Accordingly, signiﬁcant anomalous difference density (contoured
at 5 r.m.s. and shown in brown) was only found at EF-1. Each view is oriented such that the bidentate ligand (Asp34, Glu85 and Glu130) is on the left.
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R-factor values are slightly worse than would be expected for a
structure of this resolution; we attribute this to crystal quality
since the diffraction spots displayed some splitting. However,
radiation damage did not seem to be signiﬁcant during data
collection.
The electron-density map obtained for the gadolinium
co-crystal showed a large peak of positive difference density
(18.3 r.m.s.) at EF-1 (Fig. 1). Since all metal ions were omitted
from the model at this stage, positive difference density was
expected at the remaining two calcium-binding sites, and
accordingly peaks of 7.6 r.m.s. and 6.7 r.m.s. were found at
EF-2 and EF-3, respectively, suggesting that these are still
occupied by Ca2+ rather than Gd3+. The binding of Gd3+ to
EF-1 was corroborated by the calculation of an anomalous
difference map in which the highest peak (6.7 r.m.s.) was
found to occur at this site, whereas no signiﬁcant peaks were
found at EF-2 or EF-3. In the complex Gd3+ is the only
signiﬁcant anomalous scatterer, with a theoretical f 00 of 6 e at
the wavelength used for data collection (0.92 A˚). The ﬁnal
model of the crystal structure contains a Gd3+ ion bound at
EF-1, with Ca2+ ions bound at EF-2 and EF-3 and 30 water
molecules. This model was reﬁned using data within a reso-
lution range of 27.4–2.2 A˚ to an R factor of 21.50% and an
Rfree of 30.44%. Structure validation by MolProbity (Davis et
al., 2007; Chen et al., 2010) showed that 88% of residues were
within the most favoured region of the Ramachandran plot
and no residues were classed as outliers. The model has a
mean isotropic B-factor value of 61.10 A˚2 for all atoms in the
model, which is a rather high value, but this again is probably a
reﬂection of crystal quality. Validation of the metal-binding
site geometry with CheckMyMetal (Zheng et al., 2014) indi-
cated that the model of the Gd3+-binding site is plausible.
The structure of the Gd3+ complex superimposes with the
native structure of calexcitin with a C r.m.s. deviation of
0.66 A˚ (Fig. 2). This value is slightly higher than might be
expected, but is best explained by the different crystal-packing
environment of the complex, which is non-isomorphous with
the native structure. Accordingly, the regions with the largest
deviations are the non-EF-hand loops, which interact with
symmetry-related molecules in the two crystal forms and lack
the stabilizing inﬂuence of a bound metal ion. The metal-
binding geometry of the Gd3+ site is very similar to that of the
native Ca2+-bound protein, emphasizing that Gd3+ is a judi-
cious choice to replace Ca2+. The structures of the other metal-
binding sites (EF-2 and EF-3) are very similar to those of the
native protein, as would be expected since these are most
likely to have retained Ca2+. However, the metal-bound water
molecules, which are visible in the higher resolution electron
density for the native protein, do not appear to be resolved in
the map for the Gd3+ complex and this is likely to be owing to
the higher mean B factor of the Gd3+ complex as well as the
lower crystal and data quality, which are typical of heavy-
atom-substituted proteins.
4. Discussion
We have determined the structure of the neuronal signalling
protein calexcitin crystallized in the presence of equimolar
Gd3+ and only trace levels of Ca2+. Since Gd3+ was found to
bind exclusively at EF-1, this site may be the most prone to
binding exogenous metal ions when the protein is in a low
Ca2+ concentration. The conditions of our experiment were
such that the protein was partially demetallated by dialysis
prior to the addition of Gd3+. Our ﬁnding that Gd3+ binds
exclusively to EF-1 suggests that this is the ﬁrst site to lose its
Ca2+ ion as the Ca2+ concentration decreases. Indeed, earlier
studies suggested that the N-terminal domain has mixed Ca2+/
Mg2+-binding sites and that the C-terminal site has a higher
speciﬁc afﬁnity for Ca2+ (Gombos et al., 2003). Thus, we
propose that EF-2 and EF-3 retained a bound Ca2+ ion
following the dialysis step. It is interesting that the second site
has a number of acidic residues nearby such that a Ca2+ ion
attempting to dissociate might be rapidly pulled back by
electrostatic forces. The unique structural nature of EF-3,
owing to the lack of a functional partner EF-hand in the C-
terminal domain and its proximity to the unusual C-terminal
310-helix which is implicated in GTPase activity, make it
difﬁcult to speculate on its relative afﬁnity for calcium ions,
but our results suggest that it is also a high-afﬁnity Ca2+-
binding site. Our suggestion that EF-1 is the ﬁrst to lose its
bound Ca2+ as the buffer Ca2+ concentration decreases is
consistent with the occurrence of an aspartate residue (Asp34)
as the bidentate metal ligand (Fig. 1). In contrast, EF-2 and
EF-3 have glutamate residues at this position (Glu85 and
Glu130) and this is associated with high selectivity for Ca2+.
Indeed, mutational studies of other EF-hand proteins have
shown that the presence of aspartate rather than glutamate as
the bidentate metal ligand decreases the selectivity for Ca2+
(see, for example, Cox et al., 1979; Da Silva et al., 1995; Cates et
al., 1999). In addition, this ﬁnding is in agreement with studies
on calmodulin, which showed that Mg2+ preferentially binds to
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Figure 2
Superposition of the structure of the calexcitin–Gd3+ complex with the
native protein. The folds of the Gd3+ complex and the native protein are
coloured gold and cream, respectively, and the metal-binding sites,
numbered 1–3, are shown as grey spheres.
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EF-1 and EF-4 in the absence of Ca2+ and that EF-3 has
the lowest afﬁnity for Mg2+ (Ohki et al., 1997). It is worth
remembering that the fourth EF-hand of calexcitin has lost its
ability to bind metal ions, which might be owing to its putative
GTPase activity.
Our evidence that EF-1 of calexcitin has the lowest Ca2+-
afﬁnity site is signiﬁcant since it opens an interesting line of
enquiry into how metal binding triggers structural transitions
that enable calexcitin to functionally interact with protein
partners and mediate its putative GTPase activity. An
important observation in this respect is that of all of the metal-
binding sites of calexcitin, EF-1 is the closest to the hydro-
phobic domain interface, which is known to be considerably
affected by ﬂexible protein motion (Erskine et al., 2015).
Earlier studies suggested that the binding of metal ions to the
N-terminal domain reduces its molten-globule nature, thereby
stabilizing the protein (Gombos et al., 2003). During neuronal
activation, the binding of Ca2+ to EF-1 as the Ca2+ concen-
tration increases might cause an ordering of the hydrophobic
residues which form the domain interface. Indeed, it is the
domain interface which plays a key role in the interactions
of EF-hand proteins with partner molecules in signalling
cascades. It is important to bear in mind that both Ca2+ and
Mg2+ are likely to bind to the protein, even though the overall
afﬁnity for Ca2+ is several orders of magnitude greater than
that for Mg2+. However, the intracellular concentration of
Mg2+ is at least several orders of magnitude greater than the
concentration of Ca2+, and Mg2+ can thus compete very
effectively with Ca2+ for the binding sites, especially when the
intracellular Ca2+ concentration is low, for example in quies-
cent neurons. Gombos et al. (2003) argue that calcium
signalling involves a constant competition between Ca2+ and
Mg2+ for binding sites in signalling proteins and their experi-
mental studies indicate that the N-terminal domain of calex-
citin possesses two mixed Ca2+/Mg2+-binding sites, whereas the
C-terminal domain probably has a more speciﬁc Ca2+-binding
site. Fully Ca2+-bound calexcitin has been shown by solution
NMR to undergo quite a drastic domain movement that is
most likely to expose the hydrophobic inter-domain cleft and
could then allow it to interact with partner proteins in
signalling cascades (Erskine et al., 2015). Indeed, these studies
indicate that the fully Ca2+-occupied form of calexcitin is
predominantly in a domain-opened state in solution and thus
the binding of Ca2+ to all three sites of calexcitin must trigger it
to adopt a conformation which is capable of interacting with
partner proteins. This is in agreement with studies performed
on calmodulin, which have shown that the full conformational
change upon calcium binding does not occur until all sites are
occupied by Ca2+ following the displacement of Mg2+ from the
protein (Malmendal et al., 1999).
Thus, our results have corroborated previous ﬁndings on the
Ca2+ afﬁnities of the different metal-binding sites of calexcitin
(Gombos et al., 2003) and have provided some perspective on
the previous conclusions that the C-terminal binding site is
the sensor site (Erskine et al., 2015). Furthermore, our new
evidence that the N-terminal site is the lowest-afﬁnity Ca2+
site opens possible avenues for research into how the
N-terminal domain of calexcitin plays a functionally relevant
role in the signalling events of learning and memory.
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